Angiogenic imbalance, inflammation, and oxidative stress in patients with fetal growth restriction: A case-control study
Abstract
Full Text:
PDFReferences
Shrivastava D, Master A. Fetal growth restriction. J Obstet
Gynaecol India. 2020;70(2):103-10.
https://doi.org/10.1007/s13224-019-01278-4.
Chew LC, Osuchukwu OO, Reed DJ, Verma RP. Fetal growth
restriction. InStatPearls [Internet] 2024 11. PMID
Bookshelf ID: NBK562268
Mustafa HJ, Javinani A, Muralidharan V, Khalil A.
Diagnostic performance of 32 vs 36 weeks ultrasound
in predicting late-onset fetal growth restriction and
small-for-gestational-age neonates: a systematic
review and meta-analysis. Am. J. Obstet. Gynecol.
; 1;6(1).
https://doi.org/10.1016/j.ajogmf.2023.101246.
Kitase Y, Sato Y, Arai S, Onoda A, Ueda K, Go S, Mimatsu
H, Jabary M, Suzuki T, Ito M, Saito A. Establishment
of a novel fetal growth restriction model and
development of a stem-cell therapy using umbilical
cord-derived mesenchymal stromal cells. Front. Cell.
Neurosci. 2020; 28;14:212.https://doi.org/10.3389/fncel.2020.00212
Fung CM. Effects of intrauterine growth restriction on
embryonic hippocampal dentate gyrus neurogenesis
and postnatal critical period of synaptic plasticity that
govern learning and memory function. Front. Cell.
Neurosci. 2023; 16;17:1092357.
https://doi.org/10.3389/fnins.2023.1092357
Kesavan K, Devaskar SU. Intrauterine growth restriction:
postnatal monitoring and outcomes. Pediatr. Clin. N.
;1;66(2):403.https://doi.org/10.3389/fendo.2020.
Villamor-Martinez E, Kilani MA, Degraeuwe PL, Clyman RI,
Villamor E. Intrauterine growth restriction and patent
ductus arteriosus in very and extremely preterm
infants: a systematic review and meta-analysis. Front.
Endocrinol. 2019; 8;10:58.
https://doi.org/10.3389/fendo.2019.00058
Gantenbein KV, Kanaka-Gantenbein C. Highlighting the
trajectory from intrauterine growth restriction to
future obesity. 11;13:1041718. Front. Endocrinol. 2022;
https://doi.org/10.3389/fendo.2022.1041718
Vollmer B, Edmonds CJ. School age neurological and
cognitive outcomes of fetal growth retardation or
small for gestational age birth weight. Front.
Endocrinol. 2019; 28;10:186.
https://doi.org/10.3389/fendo.2019.00186
Yawno T, Sutherland AE, Pham Y, Castillo-Melendez M,
Jenkin G, Miller SL. Fetal growth restriction alters
cerebellar development in fetal and neonatal sheep.
Front. Physiol. 2019; 22;10:560.
https://doi.org/10.3389/fphys.2019.00560
Malhotra A, Allison BJ, Castillo-Melendez M, Jenkin G,
Polglase GR, Miller SL. Neonatal morbidities of fetal
growth restriction: pathophysiology and impact.
Front. Endocrinol. 2019;
;10:55.https://doi.org/10.3389/fendo.2019.00055
Bendix I, Miller SL, Winterhager E. Causes and
consequences of intrauterine growth restriction.
Front. Endocrinol. 2020; 15;11:205.
https://doi.org/10.3389/fendo.2020.00205
Lian C, Wang Y, Bao X, Yang L, Liu G, Hao D, Zhang S,
Yang Y, Li X, Meng Y, Zhang X. Dynamic prediction
model of fetal growth restriction based on support
vector machine and logistic regression algorithm.
Front. Surg. 2022; 23;9:951908.
https://doi.org/10.3389/fsurg.2022.951908
Armengaud JB, Yzydorczyk C, Siddeek B, Peyter AC,
Simeoni U. Intrauterine growth restriction: Clinical
consequences on health and disease at adulthood.
Reprod. Toxicol. 2021; 1;99:168-76.
https://doi.org/10.1016/j.reprotox.2020.10.005.
Woods L, Perez-Garcia V, Hemberger M. Regulation of
placental development and its impact on fetal
growth—new insights from mouse models. Front.
Endocrinol. 2018; 27;9:570.
https://doi.org/10.3389/fendo.2018.00570
Salavati N, Smies M, Ganzevoort W, Charles AK, Erwich
JJ, Plösch T, Gordijn SJ. The possible role of placental
morphometry in the detection of fetal growth
restriction. Front. Physiol. 2019; 8;9:1884.
https://doi.org/10.3389/fphys.2018.01884
Varberg KM, Soares MJ. Paradigms for investigating
invasive trophoblast cell development and
contributions to uterine spiral artery remodeling.
Placenta. 2021; 15;113:48-56.
https://doi.org/10.1016/j.placenta.2021.04.012.
Umapathy A, Chamley LW, James JL. Reconciling the
distinct roles of angiogenic/anti-angiogenic factors in
the placenta and maternal circulation of normal and
pathological pregnancies. Angiogenesis. 2020;
(2):105-17. https://doi.org/10.1007/s10456-019
-w.
Cerdeira AS, Kandzija N, Pargmae P, Tome M, Zhang W,
Cooke WR, Agrawal S, James T, Redman C, Vatish
M. In vivo evidence of significant placental growth
factor release by normal pregnancy placentas. Sci.
Rep. 2020; 10;10(1):132.
https://doi.org/10.1038/s41598-019-56906-w.
Hoeller A, Ehrlich L, Golic M, Herse F, Perschel FH, Siwetz
M, Henrich W, Dechend R, Huppertz B, Verlohren S.
Placental expression of sFlt-1 and PlGF in early
preeclampsia vs. early IUGR vs. age-matched healthy
pregnancies. Hypertens Pregnancy. 2017;
;36(2):151-60.
https://doi.org/10.1080/10641955.2016.1273363.
Schoots MH, Gordijn SJ, Scherjon SA, van Goor H,
Hillebrands JL. Oxidative stress in placental
pathology. Placenta. 2018; 1;69:153-61.
https://doi.org/10.1016/j.placenta.2018.03.003.
Vangrieken P, Al-Nasiry S, Bast A, Leermakers PA, Tulen
CB, Janssen GM, Kaminski I, Geomini I, Lemmens T,
Schiffers PM, van Schooten FJ. Hypoxia-induced
mitochondrial abnormalities in cells of the placenta.
PLoS one. 2021; 12;16(1):e0245155.
https://doi.org/10.1371/journal.pone.0245155.
Mochan S, Dhingra MK, Varghese B, Gupta SK, saxena S,
Arora P, Rani N, Sharma A, Luthra K, Dwivedi S,
Bhatla N. sFlt-1 (sVEGFR1) induces placental
endoplasmic reticulum stress in trophoblast cell:
implications for the complications in preeclampsia-an
in vitro study. bioRxiv. 2017; 28:240481.
https://doi.org/10.1101/240481
Baker BC, Heazell AE, Sibley C, Wright R, Bischof H,
Beards F, Guevara T, Girard S, Jones RL. Hypoxia
and oxidative stress induce sterile placental
inflammation in vitro. Sci. Rep. 2021;
;11(1):7281.https://doi.org/10.1038/s41598-021
-1.
Socha MW, Malinowski B, Puk O, Wartęga M, Stankiewicz
M, Kazdepka-Ziemińska A, Wiciński M. The role of
NF-κB in uterine spiral arteries remodeling, insight
into the cornerstone of preeclampsia. Int. J. Mol. Sci.
; 12;22(2):704.
https://doi.org/10.3390/ijms22020704.
Medina-Bastidas D, Guzmán-Huerta M, Borboa-Olivares H,
Ruiz-Cruz C, Parra-Hernández S, Flores-Pliego A,
Salido-Guadarrama I, Camargo-Marín L, Arambula
Meraz E, Estrada-Gutierrez G. Placental microarray
profiling reveals common mRNA and lncRNA
expression patterns in preeclampsia and intrauterine
growth restriction. Int. J. Mol. Sci. 2020;
;21(10):3597.
https://doi.org/10.3390/ijms21103597.
Ravikumar G., Mukhopadhyay A., Mani C., Kocchar P.,
Crasta J., Thomas T. Placental expression of
angiogenesis-related genes and their receptors in
IUGR pregnancies: correlation with fetoplacental and
maternal parameters, J. Matern. -Fetal Neonatal Med.
; 1;33(23):3954-61.
https://doi.org/10.1080/14767058.2019.1593362.
Atallah A, Butin M, Moret S, Claris O, Gaucherand P, Doret
Dion M. Fetal growth restriction: underdiagnosed
condition with non-optimal screening. J. Matern.
Fetal Neonatal Med. 2022; 12;35(25):8237-44.
https://doi.org/10.1080/14767058.2021.1967924.
King VJ, Bennet L, Stone PR, Clark A, Gunn AJ, Dhillon
SK. Fetal growth restriction and stillbirth: Biomarkers
for identifying at risk fetuses. Front. Physiol. 2022;
;13:959750.
https://doi.org/10.3389/fphys.2022.959750
Li T, Wang Y, Miao Z, Lin Y, Yu X, Xie K, Ding H.
Neonatal adverse outcomes of induction and
expectant management in fetal growth restriction: a
systematic review and Meta-analysis. Front. Pediatr.
; 30;8:558000.
https://doi.org/10.3389/fped.2020.558000
Wang X, Zhu H, Lei L, Zhang Y, Tang C, Wu JX, Zhou JR,
Xiao XR. Integrated analysis of key genes and
pathways involved in fetal growth restriction and their
associations with the dysregulation of the maternalimmune system. Front. Genet. 2021; 8;11:581789.
https://doi.org/10.3389/fgene.2020.581789
Paauw ND, Lely AT, Joles JA, Franx A, Nikkels PG, Mokry
M, Van Rijn BB. H3K27 acetylation and gene
expression analysis reveals differences in placental
chromatin activity in fetal growth restriction. Clin.
Epigenetics.
;
:1-1.
https://doi.org/10.1186/s13148-018-0508-x.
Sifakis S, Androutsopoulos VP, Pontikaki A, Velegrakis A,
Papaioannou GI, Koukoura O, Spandidos DA,
Papantoniou N. Placental expression of PAPPA,
PAPPA-2 and PLAC-1 in pregnacies is associated
with FGR. Mol. Med. Rep. 2018; 1;17(5):6435-40.
https://doi.org/10.3892/mmr.2018.8721.
Harris LK, Pantham P, Yong HE, Pratt A, Borg AJ, Crocker
I, Westwood M, Aplin J, Kalionis B, Murthi P. The
role of insulin-like growth factor 2 receptor-mediated
homeobox gene expression in human placental
apoptosis, and its implications in idiopathic fetal
growth restriction. Mol. Hum. Reprod. 2019;
(9):572-85. https://doi.org/10.1093/molehr/gaz047.
Lee S, Kim YN, Im D, Cho SH, Kim J, Kim JH, Kim K.
DNA Methylation and gene expression patterns are
widely altered in fetal growth restriction and
associated with FGR development. Anim. Cells Syst.
;
;25(3):128-35.
https://doi.org/10.1080/19768354.2021.1925741.
Martinez-Fierro ML, Garza-Veloz I, Carrillo-Sanchez K,
Martinez-Gaytan V, Cortes-Flores R, Ochoa-Torres
MA, Guerrero GG, Rodriguez-Sanchez IP, Cancela
Murrieta CO, Zamudio-Osuna M, Badillo-Almaraz JI.
Expression levels of seven candidate genes in human
peripheral blood mononuclear cells and their
association with preeclampsia. Hypertens Pregnancy.
;
;33(2):191-203.
https://doi.org/10.3109/10641955.2013.853777.
Cardenas-Mondragon MG, Vallejo-Flores G, Delgado
Dominguez J, Romero-Arauz JF, Gomez-Delgado A,
Aguilar-Madrid G, Sanchez-Barriga JJ, Marquez
Acosta J. Preeclampsia is associated with lower
production of vascular endothelial growth factor by
peripheral blood mononuclear cells. Archives of
medical research. 2014 Oct 1;45(7):561-9
https://doi.org/10.1016/j.arcmed.2014.10.004.
Ali Z, Khaliq S, Zaki S, Ahmad HU, Lone KP. Altered
Expression of Vascular Endothelial Growth Factor,
Vascular Endothelial Growth Factor Receptor-1,
Vascular Endothelial Growth Factor Receptor-2, and
Soluble FMS-like Tyrosine Kinase-1 in Peripheral
Blood Mononuclear Cells from Normal and
Preeclamptic Pregnancies. Chin. J. Physiol. 2019;
:117-22. https://doi.org/10.4103/CJP.CJP_15_19.
Ali Z, Zafar U, Khaliq S, Lone KP. Elevated tumor necrosis
factor (TNF)-α mRNA expression correlates with
nuclear factor kappa B expression in peripheral blood
mononuclear cells in preeclampsia. J Coll Physicians
Surg Pak. 2020; 1;30(2):158-62.
https://doi.org/10.29271/jcpsp.2020.02.158
Ali Z, Khaliq S, Zaki S, Ahmad HU, Lone KP. Comparative
gene expression analysis of Fas and related genes in
preeclamptic and healthy women: A cross-sectional
study. Int J Reprod Biomed. 2020; 18(4):235.
https://doi.org/10.18502/ijrm.v13i4.6886.
Alahakoon TI, Medbury H, Williams H, Fewings N, Wang
X, Lee V. Maternal Flt-1 and endoglin expression by
circulating monocyte subtype and polarization in
preeclampsia and fetal growth restriction. Eur J Obstet
Gynecol Reprod Biol X. 2019; 1;3:100024.
https://doi.org/10.1016/j.eurox.2019.100024.
Chew, L.C. and Verma, R.P., Fetal growth restriction, 2020.
Bookshelf ID: NBK562268PMID: 32965939
De Leon JA, Borges CR. Evaluation of oxidative stress in
biological samples using the thiobarbituric acid
reactive substances assay. J Vis Exp. 2020;
(159):10-3791. https://doi.org/10.3791/61122.
Stefanov G, Briyal S, Pais G, Puppala B, Gulati A.
Relationship between oxidative stress markers and
endothelin-1 levels in newborns of different
gestational ages. Front. Pediatr. 2020; 2;8:279.
https://doi.org/10.3389/fped.2020.00279.
Ellman GL. Tissue sulfhydryl groups. Arch. Biochem.
Biophys. 1959; 1;82(1):70-7.
https://doi.org/10.1016/0003-9861(59)90090-6.
Razygraev AV, Arutiunian AV. Determination of human
serum glutathione peroxidase activity, by using
hydrogen peroxide and 5, 5'-dithio-bis (2-nitrobenzoic
acid). Klin. Lab. Diagn. 2006; 1(6):13-6.
https://doi.org/10.1007/s11696-021-01826-1.
Oxford Biomedical Research. Spectrophotometric Assay for
Glutathione Reductase. Michigan: Oxford Biomedical
Research; 2001.
Rebouças ED, Costa JJ, Passos MJ, Passos JR, Hurk RV,
Silva JR. Real time PCR and importance of
housekeepings genes for normalization and
quantification of mRNA expression in different
tissues. Braz. Arch. Biol. Technol. 2013; 56:143-54.
https://doi.org/10.1590/S1516-89132013000100019
Consultation WH. Obesity: preventing and managing the
global epidemic. World Health Organization technical
report series. 2000; 894:1-253.
Fritz CO, Morris PE, Richler JJ. Effect size estimates:
current use, calculations, and interpretation. J. Exp.
Psychol. 2012; 141(1):2.
https://doi.org/10.1037/a0024338
Deinichenko O.V., Sіusіuka V.G., Krut’ YuYа,
Pavlyuchenko M.I., Puchkov V.A., Shevchenko A.O.
Clinical and pathogenetic mechanisms of formation of
fetal growth retardation. Reprod. health woman.2023;
(2023) 8. 8731.3.2023.283320
https://doi.org/10.30841/2708
Jardine J, Walker K, Gurol-Urganci I, Webster K, Muller P,
Hawdon J, Khalil A, Harris T, van der Meulen J.
Adverse pregnancy outcomes attributable to
socioeconomic and ethnic inequalities in England: a
national cohort study. 20;398(10314):1905-12. Lancet. 2021;
https://doi.org/10.1016/S0140-6736(21)01595-6.
Lewandowska M, Więckowska B, Sztorc L, Sajdak S.
Smoking and smoking cessation in the risk for fetal
growth restriction and low birth weight and additive
effect of maternal obesity. J. Clin. Med. 2020;
;9(11):3504. https://doi.org/10.3390/jcm9113504.
Gaccioli F, Charnock-Jones DS, Smith GC. Maternal
Circulating Nucleic Acids as Markers of Placental
Health. InNoninvasive Prenatal Testing (NIPT) 2018;
(pp.
-351).
Academic
Press.
https://doi.org/10.1016/B978-0-12-814189-2.00019
Whitehead CL, McNamara H, Walker SP, Alexiadis M,
Fuller PJ, Vickers DK, Hannan NJ, Hastie R, Tuohey
L, Tu’uhevaha J, Tong S. Identifying late-onset fetal
growth restriction by measuring circulating placental
RNA in the maternal blood at 28 weeks’ gestation. Am
J
Obstet
Gynecol.
;
;214(4):521-e1.
https://doi.org/10.1016/j.ajog.2016.01.191.
Rajakumar A, Cerdeira AS, Rana S, Zsengeller Z, Edmunds
L, Jeyabalan A, Hubel CA, Stillman IE, Parikh SM,
Karumanchi SA. Transcriptionally active syncytial
aggregates in the maternal circulation may contribute
to circulating soluble fms-like tyrosine kinase 1 in
preeclampsia. Hypertension. 2012; 59(2):256-64.
https://doi.org/10.1161/HYPERTENSIONAHA.111.
Tsang JC, Vong JS, Ji L, Poon LC, Jiang P, Lui KO, Ni YB,
To KF, Cheng YK, Chiu RW, Lo YM. Integrative
single-cell and cell-free plasma RNA transcriptomics
elucidates placental cellular dynamics. PNAS. 2017;
;114(37):E7786-95.
https://doi.org/10.1073/pnas.1710470114.
Matin M, Mörgelin M, Stetefeld J, Schermer B, Brinkkoetter
PT, Benzing T, Koch M, Hagmann H. Affinity
enhanced multimeric VEGF (vascular endothelial
growth factor) and PlGF (placental growth factor)
variants for specific adsorption of sFlt-1 to restore
angiogenic balance in preeclampsia. Hypertension.
;76(4):1176-84.
https://doi.org/10.1161/HYPERTENSIONAHA.120.
Spiel M, Salahuddin S, Pernicone E, Zsengeller Z, Wang A,
Modest AM, Karumanchi SA, Hecht JL. Placental
soluble fms-like tyrosine kinase expression in small
for gestational age infants and risk for adverse
outcomes.
Placenta.
;
;52:10-6.
https://doi.org/10.1016/j.placenta.2017.02.011.
Gaccioli F, Sovio U, Gong S, Cook E, Charnock-Jones DS,
Smith GC. Increased placental sFLT1 (soluble fms
like
tyrosine
kinase receptor-1) drives the
antiangiogenic profile of maternal serum preceding
preeclampsia but not fetal growth restriction.
Hypertension.
;
(2):325-34.
https://doi.org/10.1161/HYPERTENSIONAHA.122.
Wallner W, Sengenberger R, Strick R, Strissel PL, Meurer
B, Beckmann MW, Schlembach D. Angiogenic
growth factors in maternal and fetal serum in
pregnancies complicated by intrauterine growth
restriction.
Clin.
Sci.
:
;112(1):51-7.
https://doi.org/10.1042/CS20060161.
Schlembach D, Wallner W, Sengenberger R, Stiegler E,
Mörtl M, Beckmann MW, Lang U. Angiogenic
growth factor levels in maternal and fetal blood:
correlation with Doppler ultrasound parameters in
pregnancies complicated by pre‐eclampsia and
intrauterine growth restriction. Ultrasound Obstet
Gynecol.
;
https://doi.org/10.1002/uog.3930.
(4):407-13.
Mitlid-Mork B, Bowe S, Staff AC, Sugulle M. Alterations in
maternal sFlt-1 and PlGF: Time to labor onset in term
/late-term pregnancies with and without placental
dysfunction. Pregnancy Hypertens. 2022; 1;30:148
https://doi.org/10.1016/j.preghy.2022.10.004.
Fuenzalida B, Kallol S, Zaugg J, Mueller M, Mistry HD,
Gutierrez J, Leiva A, Albrecht C. Primary human
trophoblasts mimic the preeclampsia phenotype after
acute hypoxia–reoxygenation insult. Cells. 2022;
;11(12):1898.
https://doi.org/10.3390/cells11121898.
Benton SJ, Hu Y, Xie F, Kupfer K, Lee SW, Magee LA, von
Dadelszen P. Can placental growth factor in maternal
circulation identify fetuses with placental intrauterine
growth restriction?. Am J Obstet Gynecol. 2012;
;206(2):163-e1.
https://doi.org/10.1016/j.ajog.2011.09.019.
Mochan S, Bhatla N, Luthra K, Kumar R, Dwivedi S,
Sharma A, Dhingra R. Role of sVEGFR (sFlt-1) in
inducing endoplasmic reticulum stress in trophoblast
cells and its status in preeclampsia. JASI. 2018;
;67(2):93-103.
https://doi.org/10.1016/j.jasi.2018.11.003
Saker M, Mokhtari NS, Merzouk SA, Merzouk H, Belarbi
B, Narce M. Oxidant and antioxidant status in mothers
and their newborns according to birthweight. Eur J
Obstet Gynecol Reprod Biol. 2008; 1;141(2):95-9.
https://doi.org/10.1016/j.ejogrb.2008.07.013.
Cuffe JS, Xu ZC, Perkins AV. Biomarkers of oxidative stress
in pregnancy complications. Biomark. Med. 2017;
;11(3):295-306. https://doi.org/10.2217/bmm-2016
Biberoglu E, Biberoglu K, Kirbas A, Daglar K, Genc M,
Avci A, Danisman N. Circulating and myometrial
markers of oxidative stress in pregnant women with
fetal growth restriction. J Obstet Gynaecol Res. 2016;
(1):29-35. https://doi.org/10.1111/jog.12857.
Aljaser FS, Ghneim HK, ALshubaily MM, Abudawood M,
Almajed F, Fatima S, ALsheikh YA. Glutathione and
oxidized nicotinamide adenine dinucleotide (NAD+)
redox status in plasma and placental tissue of Saudi
patients with intrauterine growth restriction. Saudi
Med. J. 2021; 42(5):491.
https://doi.org/10.15537/smj.2021.42.5.20200685.
Zygula A, Kosinski P, Wroczynski P, Makarewicz-Wujec
M, Pietrzak B, Wielgos M, Giebultowicz J. Oxidative
Stress Markers Differ in Two Placental Dysfunction
Pathologies: Pregnancy‐Induced Hypertension and
Intrauterine Growth Restriction. Oxid Med Cell
Longev. 2020; 2020(1):1323891.
https://doi.org/10.1155/2020/1323891.
Celik E, Taysi S, Sucu S, Ulusal H, Sevincler E, Celik A.
Urotensin 2 and oxidative stress levels in maternal
serum in pregnancies complicated by intrauterine
growth restriction. Medicina. 2019; 2;55(7):328.
https://doi.org/10.3390/medicina55070328.
Singh A, Jaiswar SP, Priyadarshini A, Deo S. Linking of
oxidative stress and mitochondrial DNA damage to the pathophysiology of idiopathic intrauterine growth
restriction. Int. J. Health Sci. 2023;17(6):15. PMCID:
PMC10624804 PMID: 37929235
Ola AN, Lukas E, Riu DS, Previana R, Sunarno I,
Mappaware NA, Chalid MT. Increased 8-OHdG in
umbilical cord blood represents the risk of
preeclampsia with Intra-Uterine Growth Restriction
(IUGR). Bali Med. J. 2023; 12;12(3):3026-31.
https://doi.org/10.15562/bmj.v12i3.4739.
Stefanson AL, Bakovic M. Dietary regulation of
Keap1/Nrf2/ARE pathway: focus on plant-derived
compounds and trace minerals. Nutrients. 2014;
;6(9):3777-801.
https://doi.org/10.3390/nu6093777.
Mundal SB, Rakner JJ, Silva GB, Gierman LM, Austdal M,
Basnet P, Elschot M, Bakke SS, Ostrop J, Thomsen
LC, Moses EK. Divergent regulation of decidual
oxidative-stress response by NRF2 and KEAP1 in
preeclampsia with and without fetal growth
restriction.
Int.
J.
Mol.
;
;23(4):1966.https://doi.org/10.3390/ijms23041966.
Sci.
Kirici P, ÇAĞIRAN F, Kali Z, TANRIVERDI E, Mavral N,
Ecin SM. Determination of maternal serum pro
inflammatory cytokine changes in intrauterine growth
restriction. Eur Rev Med Pharmacol Sci. 2023;
;27(5):1996-2001.
https://doi.org/10.26355/eurrev_202303_31565.
Al-Azemi M, Raghupathy R, Azizieh F. Pro-inflammatory
and anti-inflammatory cytokine profiles in fetal
growth restriction. Clin Exp Obstet Gynecol. 2017;
;44(1):98-103.
https://doi.org/10.12891/ceog3295.2017
Kaya SA, Okuyan HM, Erboğa ZF, Güzel S, Yılmaz A,
Karaboğa İ. Prenatal immobility stress: Relationship
with oxidative stress, inflammation, apoptosis, and
intrauterine growth restriction in rats. Birth Defects
Res. 2023; 1;115(15):1398-410.
https://doi.org/10.1002/bdr2.2205.
Kara AE, Guney G, Tokmak A, Ozaksit G. The role of
inflammatory markers hs-CRP, sialic acid, and IL-6 in
the pathogenesis of preeclampsia and intrauterine
growth restriction. Eur. Cytokine Netw. 2019; 30:29
https://doi.org/10.1684/ecn.2019.0423.
Burton GJ, Jauniaux E. Pathophysiology of placental
derived fetal growth restriction. Am J Obstet Gynecol.
;
;218(2):S745-61.
https://doi.org/10.1016/j.ajog.2017.11.577.
Pathak R, Mustafa MD, Ahmed T, Ahmed RS, Tripathi AK,
Guleria K, Banerjee BD. Intra uterine growth
retardation: association with organochlorine pesticide
residue levels and oxidative stress markers. Reprod.
Toxicol.
;
;31(4):534-9.
https://doi.org/10.1016/j.reprotox.2011.02.007.
Gómez-Roig MD, Pascal R, Cahuana MJ, García-Algar O,
Sebastiani G, Andreu-Fernández V, Martínez L,
Rodríguez G, Iglesia I, Ortiz-Arrabal O, Mesa MD.
Environmental exposure during pregnancy: influence
on prenatal development and early life: a
comprehensive review. Fetal Diagn Ther. 2021,
;48(4):245-57.https://doi.org/10.1159/000514884.
Trocado V, Rodrigues C, Pinheiro P, Reis I, Silva CN. The
impact of maternal working conditions on fetal
weight: a risk factor for fetal growth restriction? O
impacto das condições de trabalho maternas no peso
fetal: um fator de risco para restrição de crescimento
fetal?. Acta Obstet Ginecol Port. 2020; 14(3):155-62.
Refbacks
- There are currently no refbacks.